Treatment of gout and hyperuricaemia by benzbromarone, ethyl 2 (dibromo-3,5 hydroxy-4 benzoyl)-3 benzofuran.
D001565:Benzoates / Q000627:therapeutic use; D001966:Bromine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000378:metabolism; D006073:Gout / Q000188:drug therapy* / Q000378:metabolism / Q000652:urine; D006801:Humans; D007042:Hypoxanthines / Q000652:urine; D011339:Probenecid / Q000494:pharmacology; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000188:drug therapy* / Q000378:metabolism / Q000652:urine; D011718:Pyrazinamide / Q000378:metabolism; D014527:Uric Acid / Q000097:blood / Q000378:metabolism* / Q000652:urine; D014970:Xanthines / Q000652:urine
D001565:Benzoates; D007042:Hypoxanthines; D014970:Xanthines; D014527:Uric Acid; D011718:Pyrazinamide; D003404:Creatinine; D011339:Probenecid; D001966:Bromine